Jane Street
LAB icon

Jane Street’s Standard BioTools LAB Stock Holding History

Jane Street’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,800
Closed -$165K – 10360
2021
Q2 		$165K Sell
26,800
-34,100
-56% -$182K ﹤0.01% 8972
2021
Q1 		$275K Buy
60,900
+22,900
+60% +$126K ﹤0.01% 7820
2020
Q4 		$228K Sell
38,000
-52,300
-58% -$344K ﹤0.01% 6784
2020
Q3 		$671K Buy
+90,300
New +$623K ﹤0.01% 4721

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Jane Street's LAB Position: Q2 2026 in Review

Jane Street opened a new position in Standard BioTools (LAB) in Q2 2026: 2,514,299 shares worth $2.07M. The stake represents ﹤0.01% of the portfolio and ranks #5108 among its holdings. This is a return to the name: Jane Street previously reported a position in LAB as recently as Q4 2025.

Jane Street first reported a position in LAB in Q1 2014 and has held it in 27 quarters since. The position peaked at $3.75M in Q1 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Jane Street held 2,514,299 shares of Standard BioTools worth $2.07M as of Q2 2026.
  • Standard BioTools was a new Jane Street position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5108 holding.
  • Jane Street first reported a position in Standard BioTools in Q1 2014 and has held it in 27 quarters since.
  • Jane Street's Standard BioTools position peaked at $3.75M in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.